Survival in patients with systemic lupus erythematosus (SLE) in developed countries has improved considerably over the last 2 decades. In India, however, survival in patients with SLE reported 5 years ago from this tertiary referral centre was very poor. The present study was conducted to examine tr
Survival and causes of death in patients with systemic lupus erythematosus
β Scribed by Poul Halberg
- Publisher
- Springer
- Year
- 1991
- Tongue
- English
- Weight
- 153 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0770-3198
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract We have found subnormal amounts of chemotactic activity in zymosanβtreated sera from 13 of 29 patients with systemic lupus erythematosus (SLE). As an explanation for this abnormality, the presence of a uniquely specific, heatβstable inhibitor of complement (C5)βderived chemotactic activ
## Abstract The hypothesis that corticosteroid therapy is responsible for the striking improvement in survival of patients with systemic lupus erythematosus (SLE) was investigated with two approaches: Of 250 published papers on SLE, 52 were chosen for the first analysis because they included suffic